Free Trial

Elevance Health (ELV) News Today

Elevance Health logo
$345.78 +9.57 (+2.85%)
As of 03:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Why Is Elevance Health Up Today?

Elevance Health, Inc. (NYSE:ELV) stock movement today reflects a mix of analyst revisions, legal developments and positioning ahead of the company’s upcoming Q2 earnings report.

  • Positive Sentiment: Elevance has been highlighted for stepping into opportunities as competitor UnitedHealth delays certain offerings, signaling potential market share gains for insurers. Elevance Steps In As UnitedHealth Delays
  • Neutral Sentiment: Brokerages set a $495.80 consensus price target on ELV, reflecting varied analyst views on the stock’s upside potential. Consensus Price Target
  • Neutral Sentiment: Market participants await Elevance’s Q2 results, with previews and expectations detailed in a “what to expect” earnings primer. ELV Reports Earnings Tomorrow
  • Neutral Sentiment: Investors are positioning ahead of Thursday’s earnings announcement, with detailed forecasts and trading strategies discussed. Expected to Announce Earnings
  • Neutral Sentiment: An analysis piece examines whether ELV is a buying opportunity before its upcoming earnings, leveraging historical performance around similar events. Should You Buy ELV Stock Ahead Of Earnings?
  • Neutral Sentiment: A Benzinga roundup features insights from 10 analysts on Elevance’s outlook, capturing diverse perspectives before the earnings report. Beyond The Numbers: 10 Analysts Discuss ELV
  • Negative Sentiment: Truist Financial trimmed its price target for Elevance from $500 to $440 while maintaining a “buy” rating, indicating more modest upside. Truist Lowers ELV Expectations
  • Negative Sentiment: Wells Fargo & Company cut its ELV target to $400 from $478 but kept an “overweight” rating, underscoring near-term headwinds. Wells Fargo Cuts ELV Price Target
  • Negative Sentiment: ELV shares hit a new 52-week low amid sector pressure, raising questions about whether now is the time to lighten positions. ELV Sets New 52-Week Low
  • Negative Sentiment: A shareholder lawsuit investigation has been launched against Elevance Health, adding legal uncertainty for long-term investors. Investigation Alert
Posted 58m agoAI Generated. May Contain Errors.

ELV Latest News

Elevance Health (ELV) Expected to Announce Earnings on Thursday
Get Elevance Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter.

ELV Media Mentions By Week

ELV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ELV
News Sentiment

0.72

0.97

Average
Medical
News Sentiment

ELV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ELV Articles
This Week

60

30

ELV Articles
Average Week

Get Elevance Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:ELV) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners